Michael Willenbrock

432 total citations
5 papers, 191 citations indexed

About

Michael Willenbrock is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Michael Willenbrock has authored 5 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Immunology. Recurrent topics in Michael Willenbrock's work include NF-κB Signaling Pathways (3 papers), Immune Response and Inflammation (2 papers) and Cell death mechanisms and regulation (1 paper). Michael Willenbrock is often cited by papers focused on NF-κB Signaling Pathways (3 papers), Immune Response and Inflammation (2 papers) and Cell death mechanisms and regulation (1 paper). Michael Willenbrock collaborates with scholars based in Germany and Moldova. Michael Willenbrock's co-authors include Ralf Schwanbeck, Dirk Schmidt‐Arras, Tobias Lehmann, Johannes Prox, Paul Säftig, Silvio Weber, Michael Schwake, Claus Scheidereit, Eva Kärgel and Soyoung Lee and has published in prestigious journals such as The EMBO Journal, Cellular and Molecular Life Sciences and Journal of Cachexia Sarcopenia and Muscle.

In The Last Decade

Michael Willenbrock

5 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Willenbrock Germany 4 115 53 47 31 31 5 191
Jesús Gómez-Escudero Spain 8 136 1.2× 47 0.9× 22 0.5× 33 1.1× 33 1.1× 9 231
Pei-Chieh Tien United States 5 190 1.7× 52 1.0× 72 1.5× 23 0.7× 14 0.5× 7 260
Aref G. Ebrahimi United States 7 135 1.2× 35 0.7× 67 1.4× 11 0.4× 100 3.2× 8 366
Sonia Rodríguez‐Fdez Spain 11 144 1.3× 8 0.2× 52 1.1× 30 1.0× 25 0.8× 20 239
Marina Badenes Portugal 8 176 1.5× 23 0.4× 16 0.3× 80 2.6× 46 1.5× 14 307
Gerard Hernández-Mir United States 8 96 0.8× 24 0.5× 15 0.3× 40 1.3× 130 4.2× 13 271
Alex McGregor United Kingdom 4 162 1.4× 17 0.3× 36 0.8× 24 0.8× 48 1.5× 5 242
Federica Fusella Italy 9 171 1.5× 10 0.2× 15 0.3× 27 0.9× 37 1.2× 12 230
G M Beattie United States 7 194 1.7× 13 0.2× 42 0.9× 43 1.4× 16 0.5× 9 485
Rebecca L. Daugherty United States 6 311 2.7× 19 0.4× 21 0.4× 30 1.0× 19 0.6× 9 420

Countries citing papers authored by Michael Willenbrock

Since Specialization
Citations

This map shows the geographic impact of Michael Willenbrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Willenbrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Willenbrock more than expected).

Fields of papers citing papers by Michael Willenbrock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Willenbrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Willenbrock. The network helps show where Michael Willenbrock may publish in the future.

Co-authorship network of co-authors of Michael Willenbrock

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Willenbrock. A scholar is included among the top collaborators of Michael Willenbrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Willenbrock. Michael Willenbrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Mucka, Patrick, Peter Lindemann, Michael Willenbrock, et al.. (2023). CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors. Cell chemical biology. 30(10). 1303–1312.e3. 5 indexed citations
2.
Willenbrock, Michael, et al.. (2023). A computational model of the DNA damage-induced IKK/ NF-κB pathway reveals a critical dependence on irradiation dose and PARP-1. iScience. 26(10). 107917–107917. 3 indexed citations
3.
Kolesnichenko, Marina, Uta E. Höpken, Eva Kärgel, et al.. (2021). Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence. The EMBO Journal. 40(6). e104296–e104296. 51 indexed citations
4.
Hahn, Alexander, Melanie Kny, Mihail Todiraş, et al.. (2019). Serum amyloid A1 mediates myotube atrophy via Toll‐like receptors. Journal of Cachexia Sarcopenia and Muscle. 11(1). 103–119. 43 indexed citations
5.
Prox, Johannes, Michael Willenbrock, Silvio Weber, et al.. (2012). Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10. Cellular and Molecular Life Sciences. 69(17). 2919–2932. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026